| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
TCR2 Therapeutics Inc (NASDAQ: TCRR)
TCRR Technical Analysis
5
| As on 31st May 2023 TCRR SHARE Price closed @ 1.48 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 2.81 & Strong Sell for SHORT-TERM with Stoploss of 3.83 we also expect STOCK to react on Following IMPORTANT LEVELS. |
TCRRSHARE Price
| Open | 1.58 | Change | Price | % |
| High | 1.63 | 1 Day | -0.09 | -5.73 |
| Low | 1.48 | 1 Week | -0.40 | -21.28 |
| Close | 1.48 | 1 Month | -0.15 | -9.20 |
| Volume | 3913300 | 1 Year | -3.48 | -70.16 |
| 52 Week High 5.21 | 52 Week Low 0.83 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| TCRR Daily Charts |
TCRR Intraday Charts |
Whats New @ Bazaartrend |
TCRR Free Analysis |
|
|
TCRR Important Levels Intraday
| RESISTANCE | 1.77 |
| RESISTANCE | 1.68 |
| RESISTANCE | 1.62 |
| RESISTANCE | 1.56 |
| SUPPORT | 1.40 |
| SUPPORT | 1.34 |
| SUPPORT | 1.28 |
| SUPPORT | 1.19 |
TCRR Forecast April 2024
| 4th UP Forecast | 5.26 |
| 3rd UP Forecast | 4.05 |
| 2nd UP Forecast | 3.3 |
| 1st UP Forecast | 2.55 |
| 1st DOWN Forecast | 0.41 |
| 2nd DOWN Forecast | -0.34 |
| 3rd DOWN Forecast | -1.09 |
| 4th DOWN Forecast | -2.3 |
TCRR Weekly Forecast
| 4th UP Forecast | 2.69 |
| 3rd UP Forecast | 2.30 |
| 2nd UP Forecast | 2.06 |
| 1st UP Forecast | 1.82 |
| 1st DOWN Forecast | 1.14 |
| 2nd DOWN Forecast | 0.90 |
| 3rd DOWN Forecast | 0.66 |
| 4th DOWN Forecast | 0.27 |
TCRR Forecast2024
| 4th UP Forecast | 9.92 |
| 3rd UP Forecast | 7.21 |
| 2nd UP Forecast | 5.54 |
| 1st UP Forecast | 3.87 |
| 1st DOWN Forecast | -0.91 |
| 2nd DOWN Forecast | -2.58 |
| 3rd DOWN Forecast | -4.25 |
| 4th DOWN Forecast | -6.96 |
TCR2 Therapeutics Inc ( NASDAQ USA Symbol : TCRR )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
TCRR Business Profile
TCR2 Therapeutics Inc., a clinical-stage immunotherapy company, develops novel T cell receptor therapies for patients suffering from cancer. The company's lead product candidates include gavo-cel, a mono TCR Fusion Construct T cells (TRuC-T cells) targeting mesothelin positive solid tumors, which is in phase I/II clinical trial for the treatment of non-small cell lung cancer (NSCLC), ovarian cancer, malignant pleural/peritoneal mesothelioma, and cholangiocarcinoma; and TC-110 a TRuC-T cell targeting CD19-positive B-Cell hematological malignancies, including adult acute lymphoblastic leukemia, DLBCL, follicular lymphoma, and other non-hodgkin lymphomas that is in phase I/II clinical trial. It is also developing TC-510 for, GPC3, IL-15, and Allogenic for solid tumors, as well as DC70 for solid tumors and hematological malignancies. The company was formerly known as TCR2, Inc. and changed its name to TCR2 Therapeutics Inc. in November 2016. TCR2 Therapeutics Inc. was incorporated in 2015 and is headquartered in Cambridge, Massachusetts. Address: 100 Binney Street, Cambridge, MA, United States, 02142
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service